Has Polycythemia Vera (PV) become a disease of the middle-aged?

Has Polycythemia Vera (PV) Become More Common in Younger Patients?

What is the average age of someone diagnosed with Polycythemia Vera (PV) in 2022? Are we detecting the disease earlier than before? Research suggests that PV, once considered a condition primarily affecting older adults, is now being diagnosed in patients as young as their 20s, 30s, and 40s.

📊 Key Insights from the Video:

Data from various sources indicate ET patients are diagnosed slightly younger than PV patients.
Improved screening and genetic testing may contribute to earlier detection.

A study on clonal hematopoiesis of indeterminate potential (CHIP) found that ~3% of individuals had a JAK2 mutation, potentially increasing the number of undiagnosed PV cases.

Dr. Abu-Zeinah discusses how advancements in testing and disease recognition may be shifting the median diagnosis age.

While more research is needed, these findings suggest that MPNs like PV and ET are no longer just "diseases of the elderly." More awareness and early detection could be key in improving patient outcomes.

🔬 Watch now to learn more about the changing landscape of PV diagnosis!

🌐 For more information, visit:
🔗 PV Reporter - https://www.pvreporter.com/
🔗 MPN Cancer Connection - https://mpncancerconnection.org/

👍 If you find this interview helpful, please like, subscribe, and share!

#PolycythemiaVera #MPN #BloodCancer #JAK2Mutation #MPNSpecialist #PatientAdvocacy #PVReporter #MyeloproliferativeNeoplasms